Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zamorano, J.
Right arrow Articles by Keegan, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zamorano, J.
Right arrow Articles by Keegan, A. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 12, 1479-1487, December 2001
© 2001 Japanese Society for Immunology

NF-{kappa}B activation plays an important role in the IL-4-induced protection from apoptosis

José Zamorano, Ana L. Mora1, Mark Boothby1 and Achsah D. Keegan

Department of Immunology, Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855, USA
1 Department of Microbiology and Immunology, Vanderbilt University Medical School, Nashville, TN 37232, USA

Correspondence to: A. D. Keegan

IL-4 alone protects cells from apoptosis by insulin receptor substrate (IRS)-dependent and -independent mechanisms. However, in vivocells are typically exposed to a number of signals at the same time. To determine the contribution of co-stimulatory signals to the regulation of apoptosis by IL-4, we first analyzed whether tumor necrosis factor (TNF)-{alpha}, which has been shown to inhibit the activation of IRS-1 by insulin, could modify IL-4 signaling and protection from apoptosis. We found that TNF-{alpha} cooperates with IL-4 in protecting 32D cells from factor withdrawal-induced apoptosis. This effect was independent of the expression of IRS-1, indicating that this cooperation is via an alternative anti-apoptotic pathway. Moreover, TNF-{alpha} had no effect on the activation of IRS-1 induced by IL-4. IL-4 enhanced TNF-{alpha}-induced activation of the transcription factor NF-{kappa}B. Interestingly, pharmacologic inhibition of NF-{kappa}B activation or protein synthesis resulted in the induction of cell death that could not be inhibited by IL-4, suggesting that IL-4 cooperates with NF-{kappa}B to signal protection from apoptosis. Supporting this hypothesis, IL-4 also increased NF-{kappa}B activation induced by anti-CD3 antibodies in primary T cells and protected them from apoptosis induced by receptor engagement. However, IL-4 was not able to inhibit apoptosis induced by anti-CD3 in T lymphocytes isolated from transgenic mice expressing a dominant-negative form of I{kappa}B{alpha} that prevents NF-{kappa}B activation. Thus, in addition to the previously identified IRS-1 pathway, IL-4-induced protection from apoptosis may also be mediated through cooperation with the NF-{kappa}B family of transcription factors.

Keywords: apoptosis, cytokines, T cells, transcription factors

Transmitting editor: D.T. Fearon


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
B. R. Herrin and L. B. Justement
Expression of the Adaptor Protein Hematopoietic Src Homology 2 is Up-Regulated in Response to Stimuli That Promote Survival and Differentiation of B Cells
J. Immunol., April 1, 2006; 176(7): 4163 - 4172.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Zamorano, M. D. Rivas, F. Setien, and M. Perez-G
Proteolytic Regulation of Activated STAT6 by Calpains
J. Immunol., March 1, 2005; 174(5): 2843 - 2848.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. E. Marra, Z. X. Zhang, B. Joe, J. Campbell, G. A. Levy, J. Penninger, and L. Zhang
IL-10 Induces Regulatory T Cell Apoptosis by Up-Regulation of the Membrane Form of TNF-{alpha}
J. Immunol., January 15, 2004; 172(2): 1028 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Zamorano, M. D. Rivas, A. Garcia-Trinidad, C.-K. Qu, and A. D. Keegan
Phosphatidylcholine-Specific Phospholipase C Activity Is Necessary for the Activation of STAT6
J. Immunol., October 15, 2003; 171(8): 4203 - 4209.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Moreno, M. Kaczmarek, A. D. Keegan, and M. Tondravi
IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL
Blood, August 1, 2003; 102(3): 1078 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Vasu, S. R. Gorla, B. S. Prabhakar, and M. J. Holterman
Targeted engagement of CTLA-4 prevents autoimmune thyroiditis
Int. Immunol., May 1, 2003; 15(5): 641 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z.-W. Li, S. A. Omori, T. Labuda, M. Karin, and R. C. Rickert
IKK{beta} Is Required for Peripheral B Cell Survival and Proliferation
J. Immunol., May 1, 2003; 170(9): 4630 - 4637.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Tato, A. Villarino, J. H. Caamano, M. Boothby, and C. A. Hunter
Inhibition of NF-{kappa}B Activity in T and NK Cells Results in Defective Effector Cell Expansion and Production of IFN-{gamma} Required for Resistance to Toxoplasma gondii
J. Immunol., March 15, 2003; 170(6): 3139 - 3146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Sherman, D. R. Powell, and M. A. Brown
IL-4 Induces the Proteolytic Processing of Mast Cell STAT6
J. Immunol., October 1, 2002; 169(7): 3811 - 3818.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.